Growth Inhibitory Property of Pentagamavunone-0 (PGV-0) on 4T1 Cells under Stress Condition : 2D and 3D Culture Model by Muflikhasari, Haruma Anggraini et al.
149
Muflikhasari, et al., 2019
Indones. J. Cancer Chemoprevent., 10(3), 149-158
Growth Inhibitory Property of Pentagamavunone-0 
(PGV-0) on 4T1 Cells under Stress Condition: 2D and 
3D Culture Model
Haruma Anggraini Muflikhasari1,2, Riris Istighfari Jenie2,3, Ratna Asmah Susidarti2,3, 
Edy Meiyanto2,3*
1Master Student of Biotechnology Program, Graduate School, Universitas Gadjah Mada, Indonesia
2Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah  Mada, Indonesia
3Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia
Abstract
  
 Pentagamavunone-0 (PGV-0), one of the curcumin analogue, is reported to have 
a cytotoxic effect on various cancer cells. This study aimed to explore the growth 
inhibitory effects of PGV-0 towards highly-metastatic breast cancer, 4T1 cells under stress 
condition covering 2D and 3D spheroid cytotoxic, anti-migration, and down-regulation 
of metalloproteinase-9 (MMP-9). PGV-0 showed cytotoxic activity on 2D and 3D 4T1 cells 
with IC50 value of 49 μM and 26 μM, respectively. In addition, PGV-0 performed anti-
migratory effect. The single treatment 25 μM PGV-0 and 50 μM showed inhibitory effect 
on cell migration by 54% and 51% respectively. Whilst, the combination of PGV-0 at the 
concentration of 25 μM and 50 μM with doxorubicin significantly inhibited cell migration 
by 41% and 38%, respectively. The gelatin zymography assay showed that PGV-0 down-
regulated MMP-9 expression both in a single treatment and combination with doxorubicin. 
In conclusion, PGV-0 is potential to be developed as anti-tumorigenesis agent on highly-
metastatic breast cancers.
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INTRODUCTION
Cancer metastasis is closely to the cellular 
stress response against the limited growth support 
of the microenvironment. Reactive oxygen species 
(ROS) have been shown to promote metastasis in 
various cancer cell through the molecular signal-
ling and modulate structural changes in tumor cells 
called invadopodia (Glasauer and Chandel, 2014; 
Courtneidge, 2012). Increased intracellular ROS 
levels over the threshold are known to be toxic to 
cancer cells and potentially induces cell death (Gla-
sauer and Chandel, 2014; Larasati, et al., 2018). 
The imbalance situation of ROS level is the key 
point to be the target of cytotoxic agents. This study 
is focused on the modulation of stress response 
of cancer cells against ROS generation that may 
play a role in anti-metastatic and growth-inhibi-
tory properties of anticancer agent (Courtneidge, 
2012; Kleiner Jr and Stetler-Stevenson, 1993).
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Pentagamavunone-1 (PGV-1) is one of 
the analog curcumin can target enzymes that play 
a role in ROS metabolism. A recent study showed 
that PGV-1 could increase ROS level and modu-
late cell cycle arrest at G2/M phase on 4T1 cells. 
In addition, PGV-1 performs anti-migratory effect 
through decrease metalloproteinase-9 (MMP-9) 
better than curcumin (Meiyanto, et al., 2019). Pen-
tagamavunon-0 (PGV-0) has a similar structure 
to PGV-1, has been widely reported to have anti-
cancer activity in various monolayer cancer cells 
(Meiyanto, et al., 2003; Meiyanto, et al., 2014; 
Hermawan, et al., 2011; Ikawati and Septisetyani, 
2018). In addition, PGV-0 has a specific cytotoxic 
mechanism based on the type of cancer cells allow 
PGV-0 interesting to be explored further about its 
potential as an anti-metastatic agent. Therefore, to 
study the mechanism of tumorigenesis inhibition of 
PGV-0 needs to be proven with 2D and 3D cell cul-
ture models that are represented as cellular stress.
The highly-metastatic breast cancer, 4T1 
cells, is suitable for exploring new anti-tumorigen-
esis agents targeting on cell growth and metastasis. 
The three-dimensional (3D) cancer cell model or 
commonly known as spheroid culture, is reported to 
have a micro-environmental stress condition that is 
almost the same as cancer cells in vivo. Spheroid has 
three critical zones, namely the outer zone (prolifera-
tive zone), the middle zone (quiescent zone), and the 
deepest zone (necrotic zone). Inward, cellular stress 
condition is higher, including ROS level (Cui, et al., 
2017; Nunes, et al., 2019). The outer most spheroid 
zone is more easily affected by exposure of a che-
mopreventive or chemotherapy agent. The cellular 
stress condition was used by researchers to study 
the cytotoxic effects of PGV-0 on 4T1 spheroid. 
Previous study mentioned that curcumin could trig-
ger dissociation and apoptosis in spheroid. There-
fore, curcumin analogue PGV-0 is also expected 
can inhibit the tumorigenesis of cancer spheroid.
To explore the anti-metastatic potential of 
PGV-0, in this study we used the two-dimensional 
(2D) 4T1 cells were grown by exposing cellular 
stress. Doxorubicin and serum starvation are cel-
lular stressors to induce cell migration and elevate 
MMP-9 expression. Curcumin reported to inhibit 
migration and invasion of various cancer cells. 
As a curcumin analogue, PGV-0 predicted show 
the same potential in inhibiting metastasis. There-
fore, this study also investigates the possibility of 
PGV-0 in inhibiting cell migration and suppressing 
MMP-9 expression on 4T1 cells. These findings 
will be essential as the basic exploration in clini-
cal application for highly-metastatic breast cancer.
MATERIALS AND METDHOD
Materials
 PGV-0 and Curcumin (HPLC purity grade) 
was obtained from Curcumin Research Center 
(CRC) Faculty of Pharmacy, Universitas Gad-
jah Mada. The stock solution of PGV-0 was made 
by dissolving it in dimethylsulfoxide (DMSO) 
(DMSO 99.5% pro GC, Sigma Aldrich, Darmstadt 
Germany). Doxorubicin hydrochloride injection 
(2 mg/mL) was purchased from Pharmachemie 
B.V (Swensweg, HaaerlemHolland, Netherlands).
Cell culture
 4T1 triple-negative breast cancer and Vero 
cells were obtained from Prof. Masashi Kawaichi, 
M.D., Ph.D. (Nara Institute of Science and Tech-
nology, NAIST, Nara, Japan). 3T3-L1 cells were 
obtained from Dr.med. Muhammad Hasan Bashari, 
dr., M.Kes. (Universitas Padjadjaran, Bandung, In-
donesia). The cells were maintained in Dulbecco’s 
Modified Eagles Medium (DMEM) high glucose 
(Gibco, New York, USA) with 10% fetal bovine se-
rum (FBS) (Sigma, St. Leuis, USA), HEPES, sodium 
bicarbonate, 1% v/v 1000 U/mL penicillin-1000 U/
mL of streptomycin (Gibco, New York, USA) and 
cultured in the CO2 incubator at 37°C. Cell were har-
vested from culture dish with trypsin-EDTA 0.025% 
(Gibco, New York, USA) at 80% confluence level.
Monolayer MTT Cell Viability Assay
 4T1 cells were seeded into each well of a 
96-well plate (Iwaki, Shizuoka Prefecture Haibara-
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gun, Japan) at the density of 2.5x103 cells/well. Cells 
were treated with various concentration of PGV-0, 
curcumin, and doxorubicin. After 24h of incubation, 
cell viability was assesed by MTT assay (Thermo 
Fisher, Invitrogen, New York, USA) according to 
the manufacture’s instructions (Mosmann, 1983).
Spheroid Formation and MTT Cell Viability 
Assay
Homogeneous breast cancer spheroid were 
generated according previous study. Briefly, 4T1 
cells were seeded on agarose-coated (Sigma Al-
drich, Steinheim, Germany) 96-well plate at a den-
sity of 1x104 cells followed by 2 days incubation 
for the initiation of spheroid formation. Spheroid 
were then treated with or without PGV-0, curcumin, 
and doxorubicin. After 96h incubation, spheroid 
aggregates were removed from culture plate and 
placed separately in single wells of 96-well plate 
(Iwaki). Twenty microliter of 5 mg/mL MTT solu-
tion was added to each well. The optical density 
(OD) of treated and untreated cells was deter-
mined at a wavelenght of 490 nm with a microplate 
reader after 4h incubation (Zanoni, et al., 2016).
Effect of PGV-0, Curcumin, and Doxorubicin 
on Morphological 4T1 Spheroid
Growth and morphology of the 4T1 spher-
oid were monitored for 96h as regards changes in 
area, volume, and shape. The morphological prop-
erties of spheroid were observed with inverted mi-
croscope (Olympus CKX41, Olympus Corporation, 
Tokyo, Japan), equipped with a microscope cam-
era (OptiLab, Phoenix, United States). Diameter 
of spheroid was calculated using Image Raster 
software, area and volume of spheroid were calcu-
lated using ImageJ software (Zanoni, et al., 2016).
Cell MigrationAssay
To asses the inhibition effect of 4T1 cell mi-
gration affected by PGV-0, Curcumin, and its com-
bination with doxorubicin, we conducted scratch 
wound healing. Briefly, after cells scratched, cells 
were treated or untreated with PGV-0, curcumin, 
and combination with doxorubicin. The closure 
area were captured under the inverted microscope 
(Olympus CKX41, Olympus Corporation, Tokyo, 
Japan) with camera (Samsung, Seoul, South Ko-
rea) at 0, 18, 24, and 42h. The wound closure area 
was calculated using ImageJ software. The migra-
tion activity was quantified by percentage wound 
closure (Rötzer, et al., 2016; Grada, et al., 2017):
% wound closure = [(At0h-At∆h)/At0h]×100% 
At0h = The area of the wound measured immedi-
ately after scratching (t = 0h)
AtΔh = The area of the wound measured h hours 
after the scratch is performed
MMP-9 Protein Expression Assay
 The expression level of MMP-9 was mea-
sured by gelatin zymography. The SDS-PAGE 
with the gel concentration of 8% supplemented 
with 0.1% gelatin was used to determine the ex-
pression of MMP-9 in the culture medium. Firstly, 
the protein lysate was subjected to SDS-PAGE 
electrophoresis. After electro-phoresis running, 
gels were washed and incubated at room tem-
perature. The reaction buffer was added and in-
cubated for 24h at 37°C. Gels were stained by 
using Coomassie Brilliant Blue R-250 (Sigma Al-
drich, Steinheim, Germany) and destained until 
clear bands with dark blue background appeared. 
The results were documented and analyzed by 
using ImageJ software (Hu and Beeton, 2010).
Statistical Analysis
 Data were showed as mean±SE. 
One way analysis of variance (ANOVA) fol-
lowed by the least significant difference (LSD) 
test were used for statistical analysis. P-val-
ues less than 0.01 were considered significant.
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Effect of PGV-0 and curcumin on cell viabil-
ity of monolayer 4T1
 The single treatment of PGV-0 and cur-
cumin can reduce cell viability on monolayer 
4T1 cells as the dose of the treatment increases 
(dose-dependent manner), with IC50 values of 
49±3.24 μM and 12±3.15 μM, respectively (Fig-
ure 1A). Interestingly, when PGV-0 were treated 
against Vero cells and 3T3-L1 cells, they were 
proven to 100 μM (Figure 1C-D). In contrast, cur-
cumin exerted a cytotoxic effect on 3T3-L1 cells 
with IC50 values of 33.6±2.12 μM (Figure 1D). 
Hence, the PGV-0 had a good selectivity as indi-
cated by the selectivity index (SI) ≥2 (Table 1). 
These data showed that PGV-0 potentially devel-
oped as a chemopreventive agent. The safety level 
of PGV-0 against normal cells also support this 
compound to be developed as co-chemotherapeutic 
agent. To validate these data, it is necessary to ex-
plore further PGV-0 effect on spheroid cell culture.
Effects of PGV-0 and curcumin on cell viabil-
ity and volume of spheroid 4T1
 In this study, a spheroid model of 4T1 cells 
was used as a model of triple-negative breast can-
cer (TNBC). The result showed that PGV-0 exhib-
ited a cytotoxic effect to the speroid culture with 
IC50 values of 26 μM which were not significantly 
different from the IC50 curcumin values of 23 μM 
(Figure 1B). Hence, PGV-0 was able to decrease 
spheroid volume in dose and time dependent man-
ners (Figure 2A). At the concentration of 25 μM, 
PGV-0 reduced the spheroid cells volume by 96% 
and showed a unique morphological change that 
was different. The decrease in volume seems to be 
due to the detachment process from a very com-
pact initial structure. The morphological changes 
phenomena occured very quickly after 24h incuba-
tion (Figure 2B), cells underwent detachment and 
looked to be apoptosis. Unlike the spheroid that 
was treated with curcumin, the volume reduction 
process tended to be slower because the detachment 
process occured slowly. This can be seen from the 
detachment cells around the spheroid (Figure 2B). 
These phenomena suggested that PGV-0 is interest-
ing to further explore for its anti-metastatic activity 
and its effects when combined with doxorubicin.
Effects of doxorubicin on cell viability and 
morphology against monolayer and spheroid 
4T1
 Furthermore, doxorubicin cytotoxic assay 
was conducted both on monolayer and spheroid mod-
els of 4T1 cells. The results showed that doxorubicin 
is highly cytotoxic towards monolayer and spheroid 
4T1 cells with the IC50 values of 3 μM, respectively 
(Figure 3A-B). We found that at low concentration, 
doxorubicin (10 nM) was able to induce lamellipo-
dia formation in monolayer 4T1 cells and initiated 
the formation of new spheroid aggregates around 
the primary spheroid (Figure 3C). These phenom-
ena are part of early initiation of metastatic. In this 
study, we explored the PGV-0 as a co-chemothera-
peutic agent to inhibit the breast cancer metastasis. 
Combination of PGV-0 or curcumin with 
doxorubicin inhibited 4T1 cells migration
 To examine the effect of PGV-0 to the initial 
metastatic of cancer cells we employed 4T1 cells 
under stressed by doxorubicin to observe the migra-
tion phenomenon. The single treatment of PGV-0 
at the concentration of 25 μM and 50 μM showed 
significant migration inhibitory effects compared 
to the control cell (99% confidence level) with  a 
closure percentage value up to 51% and 53%, re-
spectively. In contrast, curcumin showed an inhib-
itory effect with a closure percentage value up to 
61% at the concentration of 10 μM (Figure 4). The 
single treatment of PGV-0 inhibited the migration 
of 4T1 breast cancer cells and suppressed doxoru-
bicin-induced EMT on 4T1 cells. Interestingly, the 
combination of PGV-0 with doxorubicin showed a 
stronger migration inhibitory activity than the com-
bination of curcumin with doxorubicin. The com-
bination of PGV-0 with doxorubicin showed a clo-
sure percentage value of 38% and 41% while in the 
combination of curcumin with doxorubicin showed 
a closure percentage value of 48% and 64%.
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Combination of PGV-0 or curcumin with dx-
orubicin decreased MMP-9 expression on 
4T1 cells
 Further, we  explored  the  effect of  PGV-
0 on  the  MMP-9  expression  in 4T1 cells  under 
doxorubicin  treatment.  The  results showed  that 
a   single  treatment  of  PGV-0  was  able  to  re-
duce MMP-9  expression  better  than  curcumin. 
Interestingly,  after   the  combination  of PGV-0 
and  doxorubicin   there  was  found  a  decrease  in 
MMP-9  expression   which   was  more  significant 
(Figure 5).
Figure 1. Cytotoxic activity of pentagamavunone-0 (PGV-0) and curcumin toward breast cancer cells and normal cells. 
Cells  were  seeded  in 96 well-plate and incubated  for 24h (monolayer cells) and 96h (spheroid cells). Cell viability 
was determined by using  MTT assay as described in method.   A. 4T1 cells (2D); B. Spheroid 4T1 (3D); C. Vero cells (2D); 
D. 3T3-L1 cells. Profiles of cell viability were ± standard error of mean (SEM) of the three independent experiment.
Table 1. Cytotoxic activities and selectivity index (SI)
Sample IC50  SI 4T1 Vero  3T3-L1 (Vero)  (3T3-L1) 
PGV-0 49±3.24 142±4.94  111±2.05 2.9 2 
Curcumin  12±3.15   126±11.95    33.6±2.12 10.5  2 
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Figure 2. Effects of PGV-0 and curcumin on spheroid triple-negative breast cancer 4T1. Homogeneous–sized and 
shaped 4T1 spheroids were treated for 48h with various concentration of PGV-0 and curcumin, scale bar = 500 μm. 
A. Volume of spheroid; B. Morphology of spheroid; scale bar: 500 μm. The morphological feature and volume of 
spheroid were observed at 0, 24 and 48 hours under an inverted microscope. The arrow (      ) shows the spheroid under-
going a detachment process. Spheroid volume was quantified with ImageJ and data are mean of three repetition.
Figure 3. Cytotoxic activity of doxorubicin (Dox) in triple-negative monolayer and spheroid 4T1 cells. Cells with 
various concentrations were incubated with PGV-0 and curcumin for 24h (monolayer cells) and 96 hours (spheroid 
cells). Cell viability was obtained from by MTT treatment as described in the method. Changes in morphological 
feature and volume of spheroid were observed under an inverted microscope. A. Monolayer cells 4T1 (2D); B.Spher-
oid 4T1 (3D); C. Morphological feature of monolayer and spheroid 4T1 cells after treated, scale bar: 500 μm. The 
blackarrow ( ) indicates the spheroid has undergone a migration process, the yellow arrow ( ) indicates lamellipo-
dia, and the red arrow ( ) indicates cell apoptosis. Data were ± standard error of mean (SEM) of the three trials.
 S
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Figure 4. Effect of PGV-0 or curcumin, and its combination with doxorubicin on 4T1 cells migration. A. The morphology 
of the cells after scratch and treated with 10nM doxorubicin, PGV-0, curcumin and their combination. Observations 
were made after 0, 18, 24 and 42h of treatment under an inverted microscope with magnification of 100x, scale bar: 
500 μm. B. The percentage of 4T1 cells closure after 24h of treatment. Values were means of % closure ±SD from 
3 independent experiments. The area of the scratch were analyzed using ImageJ software then % closure was cal-
culated in accordance with the procedures of the analysis. The asterisk (*) indicates p<0.01; n = 3. Cur: Curcumin.
Figure 5. Effect of PGV-0 or curcumin and its combination with doxorubicin on MMP-9 expression. 
Cells were treated with 10 nM doxorubicin, PGV-0, curcumin, and their combination. MMP-9 expres-
sion assay was conducted using gelatin zymography according to the method. Analysis of the results were 
done by using ImageJ software to measure the intensity of gelatin degradation by MMP-9 in the gel.
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The development of curcumin analog com-
pounds is reported to be able to increase the phar-
macological and stability of curcumin. Recent stud-
ies have shown that the curcumin analog PGV-1 can 
increase ROS levels and has anti-migratory effect in 
4T1 cells (Meiyanto, et al., 2019). The PGV-0, which 
has a structure similar to PGV-1, is also thought to 
have a cytotoxic effect on 4T1 breast cancer cells 
both in monolayer and spheroid system cultures. 
Following cytotoxic assay in this study, PGV-0 and 
curcumin performed cytotoxic effect on 4T1 mono-
layer with the IC50 of 49±3.24 μM and 12±3.15 
μM, respectively. In this regards, PGV-0 performs 
medium cytotoxic activity to the cancer cells. Inter-
estingly, PGV-0 induced spheroid dissociation from 
the compact structure of spheroid at 24h incubation. 
This phenomenon indicated that the administration 
of PGV-0  may disrupt the cell integration that usu-
ally facilitated by protein integrin. However, the 
mechanism of PGV-0 towards cells separation must 
be explored further. Moreover, the distribution of 
compound on spheroid that could perform cyto-
toxic activity also interesting to be studied further.
PGV-0 tends to less cytotoxic effect com-
pared to curcumin. This phenomenon might be 
caused by the differences in polarity of two com-
pound resulting in differences in the process of dif-
fusion of compound into the cells (Chen, et al., 2012; 
Putri, et al., 2016). The concept of developing an-
ti-tumorigenesis agents or chemotherapeutic agents 
does not require a very strong cytotoxic effect, yet 
only require compounds that have spesific targets on 
cancer physiology and are able to modulate the cel-
lular development of cancer. In addition, compounds 
used as chmopreventive agents actually avoid com-
pounds that have very strong cytotoxic to minimize 
the presence of non-selective toxicity effects. An 
extract or compound is not selective if the SI value 
<2. PGV-0 have good selectivity with SI values of 
≥2 (compared to normal cells Vero and 3T3-L1). 
 Doxorubicin is an important chemo-
therapeutic agent and the most widely used in 
cancer therapy, including breast cancers. Dox-
orubicin showed cytotoxic effect on monolayer 
and spheroid 4T1 cells with the same IC50 value, 
which is about 3 μM. On the morphological ob-
servations of the spheroid model, it was known 
that there were no morphological changes in 
high-dose of doxorubicin treatment. This phe-
nomenon showed the resistance effect of spher-
oid against the high concentration of doxorubicin. 
 Doxorubicin also demonstrate a stress in-
ducing agent to cancer cells by generating ROS 
intracellular by which cancer cells exhibit malig-
nant characteristic, such as lamellipodia formation 
and cell migration (Amalina, et al., 2017; Yang, 
et al., 2017). Interestingly, PGV-0 in combina-
tion with doxorubicin was able to inhibit migra-
tion more significantly. Moreover, PGV-0 and its 
combination with doxorubicin suppressed MMP-9 
expression better than curcumin. All of these data 
suggested that PGV-0 increase the cellular stress 
leading to the suppression of the cell growth and 
may induce cell death on 4T1 cells. These phenom-
ena are suitable for co-chemotherapeutic applica-
tion that enhance the effectiveness of chemother-
apeutic agents and decrease the adverse effects.
CONCLUSION
 The curcumin analogue PGV-0 inhib-
ited cell growth, cell migration and suppressed 
MMP-9 expression in stress condition of 4T1 
cells. Therefore, PGV-0 has the potency to be de-
veloped as co-chemotherapeutic agent in met-
astatic cancer of triple-negative breast cancer.
ACKNOWLEDGMENT 
 The authors are grateful to Can-
cer Chemoprevention Research Center, Fac-
ulty of Pharmacy, Universitas Gadjah 
Mada for providing PGV-0 and curcumin.
157
Muflikhasari, et al., 2019
Indones. J. Cancer Chemoprevent., 10(3), 149-158
REFERENCES
Amalina, N.D., Nurhayati, I.P. and Meiyanto, 
E., 2017, Doxorubicin Induces Lamellipo-
dia Formation and Cell Migration, Indones. 
J. Cancer Chemoprevention, 8, 61–67. 
Chen, G., Chen, Y., Yang, N., Zhu, X., Sun, L. and Li, G., 
2012, Interaction between curcumin and mimetic 
biomembrane, Sci. China Life Sci., 55, 527–532.
Courtneidge, S.A., 2012, Cell migration and in-
vasion in human disease: the Tks adap-
tor proteins, Portland Press Limited.
Cui, X., Hartanto, Y. and Zhang, H., 2017. Ad-
vances in multicellular spheroids for-
mation, J. R. Soc. Interface, 14. 
Glasauer, A., Chandel, N.S., 2014. Tar-
geting antioxidants for cancer ther-
apy, Biochem. Pharmacol., 92, 90–101. 
Grada, A., Otero-Vinas, M., Prieto-Castrillo, F., 
Obagi, Z., Falanga, V., 2017, Research Tech-
niques Made Simple: Analysis of Collective 
Cell Migration Using the Wound Healing As-
say, J. Invest. Dermatol., 137, e11–e16.
Hermawan, A., Fitriasari, A., Junedi, S., Ikawati, 
M., Haryanti, S., Widaryanti, B., Da’i, M. and 
Meiyanto, E., 2011, PGV-0 and PGV-1 Increased 
Apoptosis Induction of Doxorubicin on MCF-7 
Breast Cancer Cells, Pharmacon, 12(2), 55-59.
Hu, X. and Beeton, C., 2010, Detection of func-
tional matrix metalloproteinases by zy-
mography, JoVE J. Vis. Exp. e2445.
Ikawati, M. and Septisetyani, E.P., 2018, Pentag-
amavunone-0 (PGV-0), a Curcumin Analog, En-
hances Cytotoxicity of 5-Fluorouracil and Mod-
ulates Cell Cycle in WiDr Colon Cancer Cells, 
Indones. J. Cancer Chemoprevention, 9(1), 23-31.
Kleiner Jr, D.E. and Stetler-Stevenson, W.G., 
1993, Structural biochemistry and ac-
tivation of matrix metalloproteases, 
Curr. Opin. Cell Biol., 5, 891–897.
Larasati, Y.A., Yoneda-Kato, N., Nakamae, I., 
Yokoyama, T., Meiyanto, E. and Kato, J., 
2018, Curcumin targets multiple enzymes in-
volved in the ROS metabolic pathway to sup-
press tumor cell growth, Sci. Rep. 8, 1–13. 
Meiyanto, E., Margono, S.A. and Da’i, M., 2003, An-
tiproliferative effect of PGV-0 (a curcumin ana-
logue) against HeLa cells, Gama Sains, 5, 200–206.
Meiyanto, E., Putri, D.D.P., Susidarti, R.A., Murwanti, 
R., Sardjiman, S., Fitriasari, A., Husnaa, U., 
Purnomo, H. and Kawaichi, M., 2014, Curcumin 
and its Analogues (PGV-0 and PGV-1) Enhance 
Sensitivity of Resistant MCF-7 Cells to Doxoru-
bicin through Inhibition of HER2 and NF-kB Acti-
vation, Asian Pac. J. Cancer Prev., 15, 179–184. 
Meiyanto, E., Putri, H., Larasati, Y.A., Utomo, R.Y., 
Jenie, R.I., Ikawati, M., Lestari, B., Yoneda-
Kato, N., Nakamae, I. and Kawaichi, M., 2019. 
Anti-proliferative and Anti-metastatic Poten-
tial of Curcumin Analogue, Pentagamavunon-1 
(PGV-1), Toward Highly Metastatic Breast Cancer 
Cells in Correlation with ROS Generation, Ad-
vanced Pharmaceutical Bulletin,  9(3), 445-452.
Meiyanto, E., Septisetyani, E.P., Larasati, Y.A. and 
Kawaichi, M., 2018, Curcumin Analog Pentag-
amavunon-1 (PGV-1) Sensitizes Widr Cells to 
5-Fluorouracil through Inhibition of NF-κB Acti-
vation, Asian Pac. J. Cancer Prev., 19(1), 49-56. 
Mosmann, T., 1983, Rapid colorimetric assay 
for cellular growth and survival: applica-
tion to proliferation and cytotoxicity as-
says, J. Immunol. Methods, 65, 55–63.
Nunes, A.S., Barros, A.S., Costa, E.C., Moreira, A.F. 
and Correia, I.J., 2019, 3D tumor spheroids as 
in vitro models to mimic in vivo human solid 
tumors resistance to therapeutic drugs: NUNES 
ET AL, Biotechnol. Bioeng., 116, 206–226. 
Putri, H., Jenie, R.I., Handayani, S., Kastian, R.F. 
and Meiyanto, E., 2016. Combination of Po-
tassium Pentagamavunon-0 and Doxorubicin 
Induces Apoptosis and Cell Cycle Arrest and 
Inhibits Metastasis in Breast Cancer Cells, 
Asian Pac J Cancer Prev., 17, 2683–2688.
Rötzer, V., Hartlieb, E., Winkler, J., Walter, E., 
Schlipp, A., Sardy, M., Spindler, V. and Waschke, 
J., 2016, Desmoglein 3-Dependent Signaling 
 158
Indonesian Journal of Cancer Chemoprevention, October 2019
ISSN: 2088–0197
e-ISSN: 2355-8989
Regulates Keratinocyte Migration and Wound 
Healing, J. Invest. Dermatol., 136, 301–310. 
Yang, J., Guo, W., Wang, L., Yu, L., Mei, H., Fang, 
S., Chen, A., Liu, Y., Xia, K. and Liu, G., 
2017, Notch signaling is important for epithe-
lial-mesenchymal transition induced by low 
concentrations of doxorubicin in osteosar-
coma cell lines, Oncol. Lett., 13, 2260–2268.
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., 
Santi, S., Polico, R., Bevilacqua, A. and Te-
sei, A., 2016, 3D tumor spheroid models for 
in vitro therapeutic screening: a systematic 
approach to enhance the biological rele-
vance of data obtained, Sci. Rep. 6, 19103.
